Insight journal - Company

Menarini: Partnering activity 2005-2013

Posted on 21 October 2013

Tags: , , ,

Menarini announced 20 partnering / licensing deals since 2005. Analysis of the partnering deals shows a strong emphasis on partnerships in oncology and central nervous system diseases.

Abstracted from: Partnering Deals and Alliances with Menarini

The number of partnering, collaborative R&D and licensing deals announced varied year on year with a peak of 14 deals announced in 2011, showing a recovery from the previous peak of 9 deals in 2007. This was probably due to the effects of the 2008 economic crisis making companies more selective in their deal making as budgets were squeezed.

The following figure shows the level of Menarini partnering deal announcements since 2005.

Figure 1: Menarini partnering deals 2005-2013

Figure 1: Menarini partnering deals 2005-2013

 

Source: Current Agreements, 2013

 

Analysis of the partnering deals shows a strong emphasis on partnerships in infectives, metabolic and musculoskeletal diseases.

The following table provides an overview of the partnering deals announced by Menarini based on therapy area disclosed. Our report provides more detailed insight into the precise therapeutic target of each deal. See: Partnering Deals and Alliances with Menarini

 

Figure 2: Menarini partnering deals by therapy area 2005-2013

Figure 2: Menarini partnering deals by therapy area 2005-2013

Source: Current Agreements, 2013

Further analysis of these deals shows that Menarini has a preference for licensing, distribution, marketing and supply similar to many other top pharmaceutical or big pharma companies. Such partnering deals provide the right for Menarini to exploit the licensors technology in return for payment of upfront, development and sales, and royalty payments.

The following table provides an overview of the partnering deals announced by Menarini based on deal type disclosed.

Figure 3: Menarini partnering deals by deal type 2005-2013

Figure 3: Menarini partnering deals by deal type 2005-2013

Source: Current Agreements, 2013

 

When looking at stage of development at partnering deal signing, the most popular stage at signing is marketed with 7 deal announcements.

The following table provides an overview of the partnering deals announced by Menarini based on stage of development at signature.

Figure 4: Menarini partnering by stage of development 2005-2013

Figure 4: Menarini partnering by stage of development 2005-2013

Source: Current Agreements, 2013

Menarini has signed 20 partnering, collaborative R&D and licensing deals since 2005. The following provides a summary of the top deals by headline value.

Figure 5: Top Menarini partnering deals by headline value 2005-2013

Figure 5: Top Menarini partnering deals by headline value 2005-2013

 

Source: Current Agreements, 2013

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Menarini

Menarini partnering at Current Agreements

View all partnering deals for Menarini: 2013 | 20122011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Deals and Alliances with Menarini

More

Summary profile data for Menarini

Partnering interests for Menarini

M&A activity for Menarini

 

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Menarini

Report: Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics

 

Available resources for deal coverage for Menarini 

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Menarini company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply